In addition to the particulars mentioned in Article 55(2) and (3) of Directive 2001/83/EC, the following particulars shall appear on the immediate packaging of advanced therapy medicinal products:
(a)
the unique donation and product codes, as referred to in Article 8(2) of Directive 2004/23/EC;
(b)
in the case of advanced therapy medicinal products for autologous use, the unique patient identifier and the statement ‘For autologous use only’.